Skip to main content

Failed specifications recalls

Recalls flagged for failed specifications, newest first. 103 recalls
FiltersSort Newest
Agency
Severity
Date
Distributed in

2 recalls

Padagis Nystatin Cream

Nystatin Cream USP is subpotent, with low assay results from stability testing.

Moderate riskFDADrug potency
Padagis Nystatin Cream

5 recalls

3 recalls

1 recall

3 recalls

1 recall

1 recall

1 recall

1 recall

2 recalls

1 recall

1 recall

1 recall

1 recall

1 recall

1 recall

Rising Pharma Enalapril Maleate Tablets

Enalapril Maleate Tablets failed impurities/degradation specifications due to an out-of-specification result in organic impurities test.

Moderate riskFDAImpurity or degradation
Rising Pharma Enalapril Maleate Tablets

2 recalls

Medline Neuro Sponges

Medline Neuro Sponges may have higher-than-expected endotoxin levels.

Moderate riskFDAFailed specifications
Medline Neuro Sponges

1 recall

1 recall

2 recalls

Teva Claravis Isotretinoin Capsules

Claravis (isotretinoin capsule, USP), 10 mg, failed impurities/degradation specifications for specific impurity Tretinoin.

Moderate riskFDAImpurity or degradation
Teva Claravis Isotretinoin Capsules

1 recall

2 recalls

Cytal Wound and Burn Matrices

Cytal Wound Matrix and Cytal Burn Matrix have an increased rate of out-of-specification endotoxin results.

Moderate riskFDAFailed specifications
Cytal Wound and Burn Matrices

1 recall

Taro Fluocinonide Cream

Fluocinonide cream failed viscosity specifications.

Moderate riskFDAFailed specifications
Taro Fluocinonide Cream

1 recall

1 recall

1 recall

1 recall

1 recall

1 recall

1 recall

1 recall

1 recall

1 recall

3 recalls

1 recall

Cipla Nilotinib Capsules

Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.

Low riskFDAFailed specifications
Cipla Nilotinib Capsules